Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-060-6 | CAS number: -
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22. August 2012 - 07. November 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well documented guideline study under GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- not applicable for UVCB substances
- EC Number:
- 939-060-6
- IUPAC Name:
- not applicable for UVCB substances
- Test material form:
- other: liquid
- Details on test material:
- Name: Initiator 94
Batch: 004IN11
according to certificate of analysis and its addendum of 1. August 2012:
purity: 32% (main component and active species: benzpinakolsilylethers
further composition: Phosphoric acid tributylester (Tributylphosphate) 19.3 %,
1,2-Benzenedicarboxylic acid-di-2-propenylester (Diallylphthalate) 8.7%;
Methylbenzene (toluol) 12.9%;
Diphenylmethanone (Benzophenone) 12.4 %;
1,1,1,1-Tetraphenylethane-1,2-diol (Benzpinakol) 14.6%
form: liquid
colour: brown
odour: aromatic
density: 1.13 g/cm3 at 20°C
Production date of batch: 16.05.2011
Expiry date of batch: 01.02.2013
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Sprague Dawley rats (SPF Caw) supplied by Elevage Janvier, France.
- Age at study initiation: 8 weeks
- Weight at study initiation: 190 g to 203 g
- Fasting period before study: food was removed on D-1.
- Housing: in a group of three in solid bottomed clear polycarbonate cages with stainless steel mesh lid, sawdust bedding changed at least 2 x weekly.
- Diet: foodstuff (M20, SDS) (ad libitum)
- Water: tap water (ad libitum)
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): approx. 10 to 15 changes per hour.
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE:
- Justification for choice of vehicle: no vehicle used - Doses:
- 2000 mg/kg (1.76 ml/kg body weight, calculated based on the density)
- No. of animals per sex per dose:
- 6
- Control animals:
- other: comparison to historical control (last control during May/June 2012).
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: every day for 14 days. on first day: D0 + 30 min, D0 +1h, D0 + 3h, D0 + 4h.
- Frequency of weighing: D0, D2, D7 and D14
- Necropsy of survivors performed: yes
- Observations: - spontaneous activity, Preyer`s reflex (noise), Respiratory rate, Convulsions, Tremors, Body temperature, Muscle tone, Palpebral opening, Pupil appearance, Salivation, Lacrymation, Righting reflex, Back hair appearance.
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality at a limit dose of 2000 mg/kg bw.
- Body weight:
- A higher body weight gain was noted in the treated animals within the 14 days post treatment compared to the historical control group.
- Other findings:
- In the first hours of the test after treatment:
- decrease in spontaneous activity (6/6)
- decrease in muscle tone (1/6)
- increased salivation (2/6)
- increased lacrymation (1/6)
- piloerection (2/6)
The animals recovered a normal behaviour at 24 hours post-dose.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Executive summary:
Initiator 94 was administred to 6 female Sprague Dawley rats at a single dose of 2000 mg/kg bw. via gavage according to OECD 423/ B.1tris (EC) regulation No. 440/2008 under GLP. No mortality occured during the study. Macroscopic examination of the animals at the end of the study did not reveal treatment releated changes in comparison to historic controls.
LD0/LD50 is higher than 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
